The profound physiological disturbances associated with severe intracerebral pathology have long been recognized. These changes have also been described in the brain dead potential organ donor but have only been studied since the early 1980s. Physiological disturbances in the brain dead organ donor result in a diffuse vascular regulatory injury and a diffuse metabolic cellular injury. The net result of these changes is an inexorable deterioration of all organs and eventual "cardiovascular death" of the patient. This paper reviews these physiological changes and the effect they may have on solid transplantable tissues, and discusses the management of brain dead organ donor with regard to these changes. Current concepts of brain death and how they may affect the interpretation of the observed physiological changes are also reviewed.
countries. The medical means by which brain death is diagnosed varies from country to country. In Australia, it requires the demonstration of irreversible loss of consciousness and irreversible loss of brainstem function.
Whilst the spectrum of medical testing required to satisfy legal definitions of brain death does vary from country to country, generally definitions fall between two categories.
1. Brain death is the death of all central neurological tissue and results in the loss of cerebral function. Diagnosis is made on the basis of clinical examination and investigations showing absence of all function at a number of levels. The demonstration of any function may preclude the diagnosis.
Those definitions that align more closely to this first definition above often require assessment of cortical function (electroencephalography etc.) as well as brainstem assessment and the presence of any neurological function (e.g. pressor response to stimuli, persistent hypothalamic-pituitary function) would be inconsistent with the diagnosis 9 • 2. Brain death is the irreversible loss of integrated neurological function, more specifically of the capacity for consciousness and the ability to breathe. Simple clinical methods for testing these functions have been devised and validated in series which correlate them with the presence of widespead neuronal death and inevitable progression to cardiac standstill 1,2 • Whilst the presence of these will usually be associated with the death of all neurological tissue as a result of common pathogenetic pathways (raised intracerebral pressure), brain death here is defined in terms of loss of functions which identify the' 'point of no return" It. These functions reside in the brainstem although the abnormalities producing them are often produced secondary to raised intracranial pressure from supratentorial lesions. Theoretically, viable nests of neural tissue may persist at the time of examination and some neurological functions may be present, but they are insufficient to allow the re-establishment of consciousness or the capacity to breathe. They will also become absent with time.
Those definitions that align closely to this second definition above will allow brain death to be certified, depending upon the results of clinical examination, providing that the necessary preconditions have been met before proceeding to brain death testing 8 • Little supportive investigation may be needed and the presence of some primitive neurological functions are not inconsistent with the diagnosis. When preconditions cannot be met or where clinical testing cannot be performed, other tests, usually of cerebral perfusion such as four vessel angiography or radionuclide scanning may be used instead of clinical testing. In the extreme, this definition may be met by a localized irreversible destructive injury to the brainstem.
Just as at the time "cardiac death" is certified there may still be viable myocardial tissue present, so the diagnosis of "brain death" does not necessarily require the demonstration that all neurological tissue is necrotic and without metabolic or electrical activity. Rather the definition is again an operational one dependent upon irreversible loss of functions of the brain. Should the presence of peripherally mediated haemodynamic or endocrine responses in brain dead patients which mimic those of live patients imply that the patient is alive? Would the definition of death as determined by the absence of cardiorespiratory function be discarded if pathological examination 60 minutes after death revealed functional myocardial cells, functional cartilage or bone? The fact that cadaver kidneys can be taken from patients and subsequently function quite well when transplanted is evidence that not all body tissues are "dead" at the time that the patient is certified dead.
THE PATHOLOGY OF BRAIN DEATH
A prerequisite of medical tests used to indicate the presence of brain death is that they should correlate with the presence of widespread neurological damage. The assessment of these changes has been difficult because of the delay between the diagnosis of brain death and the timing of subsequent cardiac standstill, and because of further autolytic change between the time of cardiac standstill and autopsy. These changes are well summarised in the review by Black 2 • He notes that the development of such changes is time related, that changes may be significantly affected by later autolytic changes and that important events in pathogenesis appeared to be direct cellular injury potentiated by a vicious cycle of failure of blood flow, hypoxia, cerebral acidosis, endothelial swelling and herniation effects.
It is difficult to state the minimum level of neurological damage which correlates with the presence of brain death by current definitions. Those definitions which align themselves closely to the u.K. criteria 8 require the presence of irremediable brainstem damage sufficient to cause the loss of all brainstem reflexes and hence the presumed permanent loss of the ability for consciousness and respiration. Whilst this may occur as an isolated brainstem injury, this is an uncommon pathology in patients being tested for brain death. Where absence of cortical function and all brain functions is required, clearly discrete damage to the brainstem alone would not be accepted as sufficient grounds for one to proceed to testing for the presence of brain death. Sporadic case reports do document brain death testing which has been performed in this group of patients and interestingly, some have been associated with lengthy survival when physiological support has been given 12
•
The commonest reason for the presence of severe brainstem dysfunction and destruction is that it has occurred as a result of "coning" consequent upon diffuse cerebral injury or space occupation with cerebral herniation. Here, brainstem destruction occurs but is an epiphenomenon following catastrophic damage to cerebral structures. The U.K. criteria for the presence of brain death are satisfied when brainstem destruction has been severe. Criteria dictated in some countries of the additional absence of cerebral activity will also be met in this group when the injury which causes "coning" also will eventually cause the loss of cerebral function.
In Black's review 2 he notes that the general findings following the clinical certification of brain death are of pan-necrosis of nervous tissue and extensive foci of necrosis throughout the cerebrum and brainstem. Inflammatory response was generally minimal, presumably due to the lack of cerebral perfusion. Widespread brains tern changes are present except in those cases where cardiac arrest and thus autopsy have occurred very shortly after fulfillment of the brain death criteria. This agrees with the proposition that death is an event occurring over time, not an instantaneous event.
Confirmatory tests such as radionuclide scanning, cerebral angiography and electro-encephalography all seek to confirm the presence of a severe cerebral injury which has initiated cerebral coning and which in the absence of brain stem function can confirm the presence of death. These tests again measure epiphenomena of the severe cerebral injury but do measure slightly different aspects of the cerebral injury. In young children, a severe cerebral insult may cause cerebral swelling and brains tern herniation, radionuclide uptake may be absent, but some cerebral perfusion may persist because the ability of the skull to expand limits secondary ischaemic damage!3. The presence of cerebral blood flow in this case does not necessarily imply that viable neurological tissue remains. Cellular death has resulted from the severe injury causing swelling and we do not need to prove that sufficient ischaemia is present to cause cellular death in its own right.
PHYSIOLOGICAL CHANGES PRECEDING DYING
In a discussion of the physiological changes of brain death, one should not exclude the significant and devastating physiological changes which may have occurred in the 24 hours before the diagnosis is made. The time at which the process leading to brain death occurs and the time at which brain death certification is performed varies considerably depending upon the criteria used to define brain death as well as multiple logistic events. Matuschak 3 followed a series of 28 patients with an admission Glasgow Coma Score of 3 in whom progression to brain death was considered likely. The mean time to progression to brain death certification was 17.9 + /-2.3 hours. Major events of hypotension, cardiac arrest, polyuria, hypokalaemia, abnormal temperature regulation together with abnormalities of arterial blood gases, urea and electrolytes and coagulation studies were seen in the pre brain death certification period. Seventy-eight periods of hypotension were identified, 800,70 of these occurring prior to brain death certification. Six patients suffered cardiac arrest, three prior to certification. All cardiac arrests occurred in a setting of hypotension. Cabrer et aI' have presented a similar series where patients at high risk of proceeding to brain death presence were studied. The mean time to certification was 22 hours. It has been recognized for many years that patients likely to fulfil brain death criteria have a high rate of cardiac arrest despite active support.
Whilst there are classical descriptions of the changes during coning in non-ventilated patients 14 , the sequence of events and physiological effects is less well defined in ventilated patients. Animal experimental models of brain death do allow some insight into the processes which are occurring during' 'coning" and help explain the observational changes noted by Matuschak. These models, well discussed by Shivalkar 15 ,  suggest that the brainstem injury due to "coning" following a severe intracerebral injury is a progressive cerebrospinal ischaemic injury beginning in the cerebrum and progressing to the pons, medulla oblongata and spinal cord in an orderly rostrocaudal fashion. Overcoming of the ischaemic threshold of the brain causes vagal activation with resultant decrease in heart rate, mean arterial pressure and cardiac output. As ischaemia progresses rostrally to approach the pons, sympathetic stimulation is added to vagal stimulation, leading to bradycardia, hypertension (Cushing's response) and an irregular breathing pattern (in spontaneously ventilating patients). As the lower end of the medulla oblongata and thus the entire brainstem becomes ischaemic, the vagal cardiomotor nucleus becomes ischaemic and there is thus unopposed sympathetic stimulation. This is associated with a hyperdynamic state characterized by tachycardia, raised mean arterial pressure and elevated cardiac output. Death of the brainstem and thus the ability to meet the criteria for brain death occurs following this. The sequence of haemodynamic changes may be known as the autonomic storm.
The severity of this autonomic storm is indicated by animal studies of catecholamine levels during the process of brain death. Where coning was initiated by an "explosive" rise in intracranial pressure (ICP), the mean adrenaline level rose 750 times and mean noradrenaline 400 times's. In addition to this autonomic storm, loss of brain function is occurring or has occurred at all levels. Destruction of primitive hypothalamic and pituitary structures results in loss of temperature regulation and endocrine control. The latter may become rapidly clinically apparent, e.g. diabetes insipidus, or may have no overt clinical effect'6.
These changes are poorly described in intensive care patients. Sometimes the changes will have already occurred or be in progress at time of ICU admission. At times their significance may not be appreciated and may be attributed to other causes. Their rate of progression and the features they manifest may presumably also be affected by treatment and by the presence of other injuries.
DOES SOMATIC DEATH INEVITABLY FOLLOW BRAIN DEATH?
Early articles by Pallis' suggested that the physiological changes following brain death are so severe that progressive somatic deterioration and cardiac standstill will inevitably occur despite extensive support. While such an argument was used to justify the validity of brain death testing as criterion for definition of death, such an argument is probably not logical and indeed is not necessary for brain death certification to be accepted as a definition of death 17 • Historically many studies suggested that somatic death would inevitably follow brain death within daysl.2.
That brain death does not necessarily always rapidly lead to somatic death has been suggested by a number of reports I8 • 20 . These have included sporadic historic reports prior to the acceptance of brain death as death'S, cases of brain dead pregnant women where active treatment has been maintained following the certification of brain death in an attempt to allow successful delivery'\ and from countries where the concept of brain death is still not accepted 20. Autopsy studies have revealed the presence of liquefied brain indicating that brain death has indeed been present and that the ability to maintain heart rhythm has not been related to the misdiagnosis of brain death I8 • 19 • Few practitioners now seek to actively maintain cardiac activity for prolonged periods following the certification of brain death and hence comprehensive literature on the rate of progression to cardiac standstill with current levels of "maximal support" is hard to gauge.
Anaesthesia and Intensive Care, Vol. 23. No. I, February, 1995 Japanese investigators have the largest experience in this area 20 • Yoshiok0 20 has shown that if haemodynamic parameters are maintained in a series of patients with adrenaline alone, cardiac standstill occurred within 48 hours (n=IO), mean duration = 24.1 (+ / -17.2) hours. If arginine vasopressin infusion were added to adrenaline infusion (n = 6), cardiac rhythm could be maintained for prolonged periods, mean duration = 23.1 (±19.1) days.
PHYSIOLOGICAL CHANGES ASSOCIATED WITH BRAIN DEATH
Given the preceeding discussion, it can be seen that two types of physiological change may be seen following the diagnosis of brain death.
1. The possibility that some neurological activity may persist is not necessarily exclusive of the diagnosis of brain death in many countries. This may take the form of primitive electrical rhythms, basic metabolic activity, primitive neurological responses or deeply seated endocrine functions. The presence of these primitive neurological functions is important in any discussion of brain death, but they are by no means the major changes seen in brain death.
2. Those changes in distant organs induced by the process of the brain dying and those due to the loss of integrated neurological function with its central role in the coordination of autonomic and other basic organ functions. These changes represent by far the major physiological changes associated with brain death.
Physiological changes occurring in organs distant from the brain at or around the time of the onset of brain death arise as a result of two major mechanisms, as follows:
a. Diffuse Vascular Regulation Injury
This injury occurs in two phases. There is an early massive sympathetic outflow produced as a consequence of cerebral ischaemia (the Cushing's reflex) and termed the "sympathetic or autonomic storm". Organs are exposed to extreme sympathetic stimulation either from direct neural stimulation or from endogenous catecholamines. This is followed by a secondary phase induced by a profound reduction in sympathetic outflow. Cardiac inotropic and chronotropic state are impaired as a result and cardiac output falls. At an organ level, the loss of autonomic tone results in inappropriate vasodilation and impaired autoregulation.
b. Diffuse Metabolic Cellular Injury
There is evidence that cellular metabolism becomes abnormal, independent of the alterations in cardiac output and autoregulation. This is believed to be an endocrine abnormality due to a lack of hypothalamic control. This deficit produces a generalized metabolic hypoxic lesion in all tissues.
Interest in the physiological changes occurring at the time of brain death was excited by the fortuitous findings of a transplant group at the Groote Schuur Hospital in Cape Town in the early 1980s".
During the development of a system for hypothermic perfusion storage of the excised heart, the group made a number of interesting observations which were subsequently explained by experimental work carried out at the same centre and at the Baptist Medical Centre in Oklahoma, U.s.A. When hearts taken from healthy anaesthetized baboons and stored in the hypothermic perfusion system for up to 48 hours were transplanted, there was immediate good function of the graft in the recipient baboon. However, hearts taken from brain dead organ donors and stored in the same system required several hours to regain adequate function in the recipient. The only difference between these groups appeared to be the fact that the donor baboons were healthy prior to organ donation, whereas the brain dead organ donors met the criteria for brain death. Brain death then appeared per se to be in some way responsible for the difference in graft function following transplantation 21
•
The Cape Town/Oklahoma group then set about examining, in experimental animals and later brain dead organ donors, the changes associated with brain death. These studies are to date the best model for the changes associated with brain death and form the basis for the description of the changes in each organ system described below. Their merit lies in the closely controlled manner in which they were performed, where the exact time of brain death is known.
There are obvious ethical constraints in similar studies in humans, where it may also be difficult to determine the exact time when brain death occurs (see above). Regardless of the timing of brain death and therefore the timing of subsequent events, there are still geographical variations in the concept of brain death. Even within the same centre it has clearly been shown that brain dead organ donors do not form an homogenous group in terms of cardiovascular events after the diagnosis of brain death 22 • The human data in brain dead organ donors, as well as those observed in the experimental animal, will be presented where this is relevant in the following description of changes in the various organs following brain death. The discussion will concentrate on the solid perfusable organs commonly transplanted. The implications for therapeutic manoeuvres with regard to the brain dead organ donors in improving graft function post transplantation will also be discussed in a later section of this review (see Implications for Management of the Potential Brain Dead Organ Donor below).
A. The cardio-pulmonary system
There is physiological, histological, biochemicaF I and electrocardiographic evidence of "damage" to the heart at the time of brain death. These changes are induced by the vascular regulatory injury and the diffuse metabolic injury. The autonomic storm results from a sudden increase in intracranial pressure (ICP) and cerebral ischaemia (Cushing's reflex), a last-ditch effort by the brain to maintain its perfusion 24 • The subsequent massive outpouring of catecholamines results in the well-recognized haemodynamic changes associated with a raised ICP. The magnitude of the rise in catecholamines and the sequelae thereof depend on the rate of rise in intracranial pressure l5
• There is an initial increase in parasympathetic tone with bradycardia 25 followed by marked sympathetic changes, with hypertension, tachycardia and vasoconstriction 21 ,23. The latter changes result in a sudden and massive increase in myocardial work and oxygen consumption. The imbalance between myocardial oxygen supply and demand results in major structural damage in the myocardium, compounded by the direct effect of catecholamines in increasing myocardial intracellular calcium levels 26 ,27. This is evidenced by a classical series of electrocardiographic changes in the baboon model described in five stages 23 : • stage I-sinus bradycardia and associated bradyarrythmias, • stage 2-sinus tachycardia, with no ischaemic changes, • stage 3-multifocal ventricular ectopic beats • stage 4-sinus tachycardia, with marked ischaemic changes and • stage 5-sinus rhythm, reduction in R wave amplitude and persistent ischaemic changes in 50070 of subjects.
Histological changes of myocyte necrosis throughout the hearts of baboons in whom brain death had been induced is described 23 • The highest incidence of these changes are in the subendocardium of the left ventricle. Necrotic changes were also seen in the conduction tissues of almost half of the subjects 23 • Of interest are the findings that stages 1 and 2 of the ECG findings are abolished by vagotomy, and the histological changes described do not occur in the sympathectomized subjece 3
•
The autonomic storm also has effects on the peripheral vasculature with marked vasoconstriction and a shift of blood volume to the capacitance vessels 21 The result is an increase in venous return and right ventricular output. The resultant pulmonary congestion associated with an increase in left atrial pressure (LAP) due to the intense vasoconstriction, may lead to the LAP exceeding the pulmonary artery pressure (PAP) momentarily21. The pulmonary capillaries may be subjected to undue hydrostatic pressure during this period and result in capillary wall disruption and the leakage of protein-rich fluid into the pulmonary interstitium, as well as interstitial haemorrhages 21 . This may partially explain the phenomenon of neurogenic pulmonary oedema. Hypothermia, a common finding in the brain dead organ donor, has additional cardiovascular consequences, i.e. bradycardia and myocardial depression as the temperature falls 16,28.29.
Immediately after the autonomic storm, there is a loss of cardiovascular tone with bradyarrythmias and vasodilation, and consequent hypotension 30 ,31. This correlates with the very low levels of circulating catecholamines seen in the animal modeF,21 and produces a dilated vascular bed, relative hypovolaemia and deficient cardiac inotropy and chronotropy. All of these occur in the setting of a myocardium which has been stressed with the events of the autonomic storm and therefore has a limited reserve. The hypotension and low cardiac output may then set up a cycle of poor myocardial and tissue perfusion, with a further decrease in myocardial performance. Highly perfused organs, such as the kidney, will suffer due to this cycle.
Following the short period (minutes) of the autonomic storm and the subsequent catecholamine deficit producing the vascular regulation injury, there are significant endocrine changes in the animal model (see E. The endocrine system, below). One of the major changes is a rapid decrease in circulating triiodothyronine (T3) which leads to a reduction in mitochondrial function and a resultant disturbance in intracellular energy production 21 ,23,32. This further decreases graft function post transplantation. In the pig model of brain death 21 , measurement of adenosine triphosphate (A TP), creatine phosphate (CP), lactate and glycogen in the myocardium showed a decrease in high energy stores (CP and glycogen) and a deterioration of myocardial function following the onset of brain death. Energy stores were maintained to some extent by anaerobic metabolism as evidenced by increased myocardial lactate levels. These findings are supported by the baboon model of brain death 26 .
The change from aerobic to anaerobic metabolism was confirmed 32 ,33 by a marked reduction in the utilization of glucose, lactate and palmitate in the brain dead pig. The reduction in pyruvate and palmitate utilization indicates a defect in mitochondrial function. Anaesthesia This information suggests global mitochondrial dysfunction, affecting the entire organism. This further bears out the biochemical changes previously described in the heart. Hormonal therapy with a combination of T 3, cortisol and insulin resulted in a reversal of this shift from aerobic to anaerobic metabolism in the brain dead pig33. The same effect was noted with only T 3 administration in the brain dead baboon 32 . The human evidence for the effect of hormonal reversal of the metabolic defect seen in the brain dead organ donor is at present conflicting 21 ,34.39.
The severity of the changes occurring at the time of brain death as they impact on the cardiovascular system is reflected in studies which show an inexorable cardiovascular decline after the diagnosis of brain death despite supportive therapy in these patients1,2. Various studies also clearly show the "wastage" of a large group of severely head-injured patients who may have proceeded to brain death due to severe cardiovascular events 4 ,40,41.
With the above information now known it does not seem logical that donor hearts are on occasion turned down on the basis of the current level of inotrope therapy alone. In our institution, brain dead organ donors are not considered for heart donation if high levels of adrenaline are required to maintain cardiovascular variables within normal limits. It is possible that a high level of inotropic support does not indicate an intrinsically poor myocardium, but rather one which has been subjected to all the events as described and is attempting to carry out its function in a milieu very deficient in circulating catecholamines and where no central control exists. A non-invasive objective test such as an echocardiogram seems appropriate to determine the responsiveness of the myocardium to exogenous catecholamines, before it is summarily rejected on the basis of inotropic support alone.
B. The kidneys
Kidneys are commonly-transplanted perfusable solid organs. The eventual function of the transplanted kidney is also affected by the extreme cardiovascular instability which the brain dead organ donor may experience in addition to the effect of the hormonal changes seen in these patients42. At the biochemical level, an elegant study by Wicomb and co-workers describes impairment of renal slice function following brain death in the pig43. Slices of renal tissue prepared from kidneys taken from brain dead pigs were compared to similar slices taken from anaesthetized pigs which had not undergone brain death. Intracellular sodium (Na)/potassium(K) ratios were then measured by absorption spectrophotometry as an indicator of kidney viability. The Na/K ATPase mechanism requires ATP produced in mitochondria to maintain the Na/K ratio, i.e. the maintenance of an ionic gradient implies adequate energy production in the cell. This study showed a deleterious effect on renal slice function by the autonomic storm, by prolonged storage and by hormonal depletion.
Renal function is also affected by the marked vasoconstriction during the autonomic storm with poor renal perfusion. This may be further exacerbated by the hypotension commonly seen in the brain dead organ donor after the autonomic storm. Once again in this study the administration of T3, cortisol and insulin resulted in an improvement in renal slice function 42 ,43. Levels of ATP in human cadaver kidneys correlate well with post-transplantation function 44 and support the animal studies above. More recently marked histological changes associated with renal dysfunction have been described in the kidneys of brain dead organ donors maintained for prolonged periods on vasopressin and adrenaline 4s .
C. The liver
As the rate of hepatic transplantation has increased 46 , the state of graft function pre-transplantation has also become of more interest. A Japanese study of hepatic tolerance to hypotension in the brain dead canine model supports the generally accepted view that the liver is resistant to hypotension and has a large physiological reserve 4 7. Physiological variables (indicies of liver energy stores and hepatic enzyme levels) and light microscopy of the liver indicate that hepatic status is well maintained in the brain dead canine model and that, in this situation, the liver has a high tolerance to hypotension 47 . This would appear to be borne out in the human with good graft function after hours of hypothermic storage of the liver graft prior to transplantation, although a six to eight hour preservation limit is generally the optimum for liver grafts4S. Scrupulous care of the potential brain dead organ donor and adequate perfusion of the liver prior to organ retrieval results in improved outcome of liver transplants47.
D. The pancreas
Initial animal studies 2 ' revealed a relative insulin lack in the brain dead experimental animal and later in the brain dead organ donor4J. A more recent study49 attempts to determine whether the hyperglycaemia commonly observed in the brain dead organ donor is indicative of endocrine pancreatic dysfunction. This study of twenty-five brain dead organ donors resulted in the recording of a high incidence of hyperglycaemia and high plasma levels of C-peptide and insulin. However, histological and immunohistological examination of pancreatic tissue after organ procurement did not reveal endocrine pancreatic dysfunction. The elevated levels of glucose, C-peptide and insulin appear to represent a peripheral resistance to insulin as seen after major trauma 49 • The role of insulin in hormonal management of the brain dead organ donor is discussed below.
E. The endocrine system
There is some disparity between the information available about endocrine function following brain death in experimental animals and that seen in human brain dead organ donors. This is not surprising when one considers the controlled manner in which brain death is studied in animals, with a uniform mechanism of brain death, a well-defined time of onset of brain death and with measurements taken prior to and at exact intervals following the event. This contrasts with the human model, where ethical constraints prohibit this type of study. In the human, interpretation of studies is limited by small numbers of subjects who suffer brain death by a variety of mechanisms and by difficulties in defining the onset of brain death. This makes comparisons with the animal data difficult. A further confounding fact is that there is interspecies variation in the endocrine changes following brain death 2 '.
The hormonal changes described following brain death fall into two categories-a: those associated with the autonomic storm and representing a short-lived massive increase in circulating catecholamines and a subsequent decline in the levels of circulating catecholamines; and b: those associated with hypothalamicpituitary dysfunction.
In the brain dead pig and baboon there is a two-to elevenfold increase in circulating dopamine, noradrenaline and adrenaline in the first five minutes after a sudden rise in ICP (onset of brain death)2'. These levels decrease to control levels by fifteen minutes after the onset of brain death and fall even further over the subsequent hours 2 '. The change in concentration of the catecholamines in the plasma translate to the haemodynamic changes described above.
Both anterior and posterior pituitary dysfunction are observed following brain death. Diabetes insipidus is common in all series of brain death 21 ,36,38 and is due to a deficiency of antidiuretic hormone (AD H), central or neurogenic diabetes insipidus, and is not due to peripheral factors (nephrogenic diabetes insipidus). Anterior pituitary dysfunction results in a marked decrease in levels of the thyroid hormones and cortisol in the experimental animal2l. In the baboon, thyroid stimulating hormone (TSH) levels remained normal in the plasma following brain death, while free triiodothyronine (T3) and thyroxine (T4) levels fell markedly, to be undetectable by sixteen hours after brain death 2 '. In the same study plasma cortisol levels initially increased and then rapidly declined (501170 of baseline at one hour). Similarly, insulin levels declined to 20% of baseline by thirteen hours. The brain dead pig also showed a marked decline in free T3 , but with a much smaller decline in cortisol and insulin 2 '.
In human brain dead organ donors 21 ,36,38, the endocrine changes are not as consistent. Novitsky et aF' describe changes similar to those seen in animals, while Howlett et aP4 dispute these findings. In a series of 31 brain dead organ donors, where hormone assays were taken at the time of organ procurement, there was no strong evidence for anterior pituitary failure following brain death 34 • Furthermore, the thyroid hormone changes were more in keeping with the sick euthyroid syndrome than with an anterior pituitary dysfunction. Novitskyet al challenged the conclusions drawn by Howlett and co-workers so and maintain that the very low level of free T3 (not measured by Howlett et al. in their study) is the most important finding, this being the defect associated with the severe metabolic impairment seen (see above). Masson and co-workers from France 36 also found very low levels of free T3, associated with normal TSH levels. A more recent German study of forty potential organ donors support the findings of Novitsky et al. with marked decreases in plasma levels of T3 and T 4, and to a lesser extent cortisop7.
Twenty-two brain dead organ donors in a series from Moscowl 8 where hormone assays were done on admission, at the time of skin incision for organ procurement and prior to excision of the heart showed the following changes; a marked fall in serum ADH, follicle stimulating hormone (FSH), prolactin (PRL), TSH, T3 and T4 occurred, while adrenocortico trophic hormone (ACTH), growth hormone (GH) and leuteinising hormone (LH) remained unchanged throughout the study period 38 . These findings, with regard to thyroid hormone, correlate with the previous studies 21 ,37. The net effect of these hormonal changes has been well described by the Cape Town/Oklahoma group21,35 with the major finding being one of mitochondrial dysfunction with impaired energy production at the cellular level (see above). This may in turn result in the loss of organ function both pre-and post-transplantation and appears to be the unifying mechanism in many of the organ/system changes described above. Anaesthesia 
F. Coagulation
Coagulation profiles in the brain dead organ donor may be adversely affected by the changes associated with the initial "stress response" (raised catecholamines and cortisol)s, with an increase in the tendency to coagulate as may commonly be seen in trauma patients and following surgeryS2. The passage of cerebral tissue into the circulation may also initiate the clotting cascade, with a consumptive coagulopathy ensuing Sl • Both of the above effects may alter focal or global organ perfusion in the potential brain dead organ donor.
G. Residual neurohumoral function
The heterogeneous nature of the human brain dead organ donor in terms of aetiology and subsequent cardiovascular response has been mentioned 22 • This heterogeneity extends to residual humoral activity. A significant pressor response to surgical stimulation in the brain dead organ donor has been documented by Wetzel et al. S4 and Pennefather and co-workers ss , although these findings conflict with those of Gramm et al. lO who invoke spinal reflexes as a cause for the haemodynamic changes seen in these patients.
IMPLICATIONS FOR MANAGEMENT OF THE POTENTIAL BRAIN DEAD ORGAN DONOR
The following discussion of management will relate management to the foregoing discussion of the physiological changes occurring at the time of brain death. There will be no attempt to address the matters of suitability as regards donation of various organs, of logistics and the work load of caring for the brain dead organ donor or of the psychological aspects of dealing with relatives.
l. Intuitive management This has been described as close application of the "rule of loos"28. That is, to maintain a systolic blood pressure above 100 mmHg, a heart rate less than 100 beats per minute and a urine flow of more than 100 ml per hour. In the light of the above discussion, this would appear simplistic. That an adequate cardiac output, perfusion pressure and organ per fusion are required in the brain dead organ donor are not disputed, merely the manner in which the rule of lOOs states the aims. General intensive care principles apply to the maintenance of an adequate circulating volume and the judicious use of inotropes to maintain a cardiac output suitable to perfuse the solid transplantable organs and will not be discussed in detail here.
Mechanical ventilation and oxygen therapy are manipulated to maintain arterial blood gases within normal limits!6. This will allow normalization of the acid-base status (and the electrolyte changes consequent upon the respiratory alkalosis) produced as a result of the moderate hyperventilation often employed in the management of raised intracranial pressure, which may have occurred prior to the diagnosis of brain death.
The autonomic storm and the subsequent loss of cardiovascular tone associated with brain death may be extremely difficult to manage, with high requirements for both alpha and beta blockade during the height of the "storm", and then the need for pressor agents in the period immediately after. Close cardiovascular monitoring and rapid response to the changes which occur, with the anticipation of trends, is required to prevent large swings in cardiovascular variables and the fluctuations in tissue perfusion and myocardial work which accompany them. Therapeutic techniques which may have been used for the treatment of severe head injury may complicate the management of the brain dead organ donor (e.g. hypovolaemia and hypernatraemia secondary to the osmotic diuresis caused by mannitol).
Management of common complications
The brain dead organ donor exhibits some or all of the following common complications, each of which requires prompt and effective treatment:
• spinal cord shock as a result of tonsillar herniation, with decreased systemic vascular resistance I6 ,5),56, in addition to the other causes of hypotension discussed above,
• diabetes insipidus (see above), with diuresis and hypotension 16,56, • Electrolyte abnormalities l6 , commonly hypernatraemia, hypokalaemia, hypomagnesaemia, hypophosphataemia and hypocalcaemia secondary to therapy such as the osmotic diuresis caused by mannitol, fluid restriction and glucocorticoid usage, and diabetes insipidus,
• hyperglycaemid 6 due to the stress response 5 t, and the peripheral insulin resistance seen in the brain dead organ donor 49 , • hypothermia due to loss of central temperature control, contributing to bradycardia and myocardial depression!6,
• coagulopathY., which may require careful haem ato logical documentation, prior to therapy with blood and blood products. Hormonal therapy described in 3. below may also be viewed as treatment of one of the complications of brain death, i.e. hormonal depletion secondary to hypothalamic-pituitary dysfunction.
Hormonal therapy
Parts I and 2 above represent the non-controversial aspects of care of the brain dead organ donor as they relate to the physiological changes seen after brain death. Hormonal therapy has been an entity only for the last ten years and there is as yet no general consensus.
The Cape Town/Oklahoma group2I,32,33,35,42,43,57-60 present compelling evidence for a post brain death depletion of the thyroid hormones. What is less clear are related hormonal changes, insulin and cortisol in particular, where there is interspecies variation and no clear metabolic defect associated with the hormonal changes.
The administration of T3 alone or in combination with cortisol and insulin, results in a rapid reversal of the defect in oxidative phosphorylation and a reversal in the human brain dead organ donor and the animal model from predominantly anaerobic cellular metabolism to aerobic metabolism 2I , 32,42,43,57,58,6o . The rapid effect of T3 in this setting is purported to be due to non-nuclear (DNA-mediated) effects of T3 60 • In addition, some of the effects may be due to activation of various ATPase systems 60 . The net effect is a rapid increase in glucose, pyruvate and palmitate use and carbon dioxide production. As the mitochondria become activated by T 3 there is a normalization of lactate and free fatty acid metabolism, with the oxidation of Krebs cycle intermediates and an increase in oxidative phosphorylation. This may be associated with a small temperature rise 35 .
There appears then to be a good reason to supplement T3 in the brain dead organ donor to treat the metabolic defect prior to organ retrieval. Both animal and controlled human trials indicate that T3 improves kidney and heart function pre-and post_transplantation 2I , 32, 35, 42, 43, 57, 58 . T3 therapy has also been used in the recipient following transplantation to improve graft function 35 ,60. The optimal dose of T3 required to reverse the metabolic defect seen in the brain dead organ donor is not known, but doses of up to 2 micro grams per hour have been used 60 ,61. It is known that excessive T3 levels result in a number of undesirable effects 62 ; increased tissue oxygen demand and consumption, uncoupling of oxidation and phosphorylation with energy wastage as heat 35 . The low levels of insulin and cortisol seen in the brain dead animal and human have not been demonstrated to be associated with specific metabolic defects, except hyperglycaemia, and the evidence for the use of cortisol and insulin, although physiologically sound, has not been proven 35 ,60. Studies from Moscow 38 and Germany)? support the findings of the above group of researchers with regard to T3 therapy in the brain dead organ donor, while a study from France 36 produced equivocal findings. Howlett et aP' dispute the T3 lesion and the case for T3 and cortisol therapy as discussed above (endocrine changes). A recent study from Finland 6 l, where T3 therapy was used only in the immediate preoperative period, did not demonstrate any haemodynamic benefit from this therapy and indeed a worsening metabolic acidosis was seen in the T3 treatment group compared to the control group. The outcome of the recipients of livers retrieved during this study was similar in both groups.
In summary, there is good evidence for the use of T3 therapy during maintenance of the brain dead organ donor to reverse the metabolic defect seen in these patients and to improve graft function posttransplantation. A large controlled trial to determine the optimum dosage of T3 in this situation is required 6o ,61.
CONCLUSION
Brain death is associated with profound physiological changes resulting in a diffuse vascular regulation injury and a diffuse metabolic cellular injury. The physiological changes also explain why the potential brain dead organ donor is such a challenge in terms of management. There is much opportunity for further study in this group as to the efficacy of hormonal therapy and its advantage to the transplant recipient. Many difficulties can be expected in the performance of such studies because of the relatively small study group and the ethical aspects of dealing with this group of patients.
